dc.creatorMartínez Cifuentes, Maximiliano
dc.creatorWeiss López, Boris
dc.creatorSantos, Leonardo S.
dc.creatorAraya Maturana, Ramiro
dc.date.accessioned2018-12-20T15:13:10Z
dc.date.available2018-12-20T15:13:10Z
dc.date.created2018-12-20T15:13:10Z
dc.date.issued2015
dc.identifierCurrent Topics in Medicinal Chemistry, Volumen 15, Issue 17, 2018, Pages 1663-1672
dc.identifier18734294
dc.identifier15680266
dc.identifier10.2174/1568026615666150427111837
dc.identifierhttps://repositorio.uchile.cl/handle/2250/158530
dc.description.abstract© 2015, Bentham Science Publishers. Curcumin, a natural yellow polyphenol, is isolated from the herb Curcuma longa L. (turmeric), a member of the ginger family. It has been extensively studied due to their multiple pharmacological properties. Nevertheless, curcumin has disadvantages such as poor water solubility, poor bioavailability and rapid metabolism, which has prompted the search for analogues that overcome these shortcomings while maintaining or improving their good pharmacological properties. Among the main curcumin analogues that have been developed, the heterocyclic curcuminoids show a high interest. In this review, we describe recent progress in the synthesis and pharmacological properties of new heterocyclic curcumin derivatives. The most recent developments in anti-cancer, anti-Alzheimer, anti-bacterial and anti-oxidants heterocyclic curcumin derivatives are covered.
dc.languageen
dc.publisherBentham Science Publishers B.V.
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceCurrent Topics in Medicinal Chemistry
dc.subjectAlzheimer
dc.subjectAntibacterial
dc.subjectAntioxidants
dc.subjectCancer
dc.subjectCurcumin
dc.subjectHeterocycles
dc.titleHeterocyclic curcumin derivatives of pharmacological interest: Recent progress
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución